Albert Ludolph

发表

Mechanisms Models and Biomarkers in Amyotrophic Lateral Mechanisms Models and Biomarkers in Amyotrophic Lateral Sclerosis Sclerosis

S. Rutkove, N. Maragakis, Kenneth H. Fischbeck, 2022 .

European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO‐NMD)

F. Salachas, P. van Damme, M. de Carvalho, 2024, European journal of neurology.

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

Timothy A. Miller, A. Pestronk, P. Andersen, 2020, The New England journal of medicine.